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Proliferation and differentiation in the epidermis must be tightly regulated. This regulation is known to involve a
range of transcription factors, including pituitary tumor transforming gene 1 (PTTG1), a ubiquitously distributed
transcription factor that regulates keratinocyte proliferation and differentiation. Psoriasis is a common but
refractory skin disorder, the pathophysiology of which is characterized by hyperproliferation and impaired
differentiation in the epidermis. The present study was conducted to clarify the less well-known roles of PTTG1 in
the pathophysiology of psoriasis, focusing on its relationship with tumor necrosis factor-a (TNF-a), which is a
critical mediator of the disease. The levels of PTTG1 expression were increased in the psoriatic epidermis.
Overexpression of PTTG1 resulted in the overproduction of TNF-a, and TNF-a itself had an inductive effect on
PTTG1 expression, suggesting that their expression may involve autoinduction. Moreover, overexpression of
PTTG1 involved augmented the expression of cyclin A and B1 proteins in both cultured keratinocytes and the
psoriatic epidermis. Therefore, enhanced expression of PTTG1 in the psoriatic epidermis may result in aberrant
regulation of the cell cycle and impaired differentiation via the interplay between PTTG1 and TNF-a.
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INTRODUCTION
Proper regulation of proliferation and differentiation in the
epidermis is indispensable for maintenance of barrier function
against the external environment (Proksch et al., 2008). This
regulation is known to involve a number of molecules, includ-
ing transcription factors (Eckert et al., 1997; Eckert et al., 2011),
the dysregulation of which results in skin disorders (Honeycutt
et al., 2004). Pituitary tumor transforming gene 1 (PTTG1), also
known as securin, is a ubiquitously distributed transcription
factor that has been shown to be involved in a number of
cellular processes, including cell cycle control, organ develop-
ment, angiogenesis, metabolism, cell transformation, and cell
senescence (Pei and Melmed, 1997; Zou et al., 1999; Tong
and Eigler, 2009). Recently, we demonstrated that PTTG1
enhanced proliferation and suppressed differentiation of
keratinocytes (Ishitsuka et al., 2012), suggesting that it may
have important roles in hyperproliferative disorders in the
epidermis, such as psoriasis and skin cancers.
Psoriasis is a common but refractory skin disorder, the
pathophysiology of which is characterized by hyperprolifera-
tion and impaired differentiation in the epidermis. Among a
range of mediators involved in the pathogenesis of psoriasis
(Proksch et al., 2008; Nestle et al., 2009), tumor necrosis
factor-a (TNF-a) has been shown to have a critical role
(Nickoloff et al., 1991). Indeed, overexpression of TNF-a has
been reported in the psoriatic epidermis (Kristensen et al.,
1993; Ettehadi et al., 1994) in addition to the dermis (Lowes
et al., 2005; Clark and Kupper, 2006). Recent advances in
biological therapy against such molecules (Langley, 2012)
revealed that neutralization of TNF-a in psoriatic lesions
restores normal epidermal differentiation (Kim et al., 2011;
Donetti et al., 2012), suggesting important roles of TNF-a in
the epidermal barrier function. Although the functions of
TNF-a in immunity and inflammation have been elucidated
(Aggarwal et al., 2012), its roles in the epidermal barrier
function are less clear. Moreover, as PTTG1 may have
important roles in keratinocyte proliferation and differ-
entiation (Ishitsuka et al., 2012), it is important to clarify the
relationship between PTTG1 and TNF-a in the epidermis
and the regulatory machinery that may lead to a deeper
understanding of the pathophysiology of psoriasis.
ORIGINAL ARTICLE
1Department of Dermatology, Faculty of Medicine, University of Tsukuba,
Tsukuba, Japan
Correspondence: Yasuhiro Kawachi, Department of Dermatology, Faculty of
Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba 305-857k5, Japan.
E-mail: kyasuhir@md.tsukuba.ac.jp
Received 26 November 2012; revised 18 March 2013; accepted 1 April
2013; accepted article preview online 18 April 2013; published online 16
May 2013
Abbreviations: EGF, epidermal growth factor; FLG, filaggrin; K1, keratin 1;
K10, keratin 10; mRNA, messenger RNA; NHK, normal human keratinocyte;
NMK, neonatal mouse keratinocyte; PBS, phosphate-buffered saline; PTTG1,
pituitary tumor transforming gene 1; RT–PCR, real-time PCR; TGF-a,
transforming growth factor-a; TNF-a, tumor necrosis factor-a
2566 Journal of Investigative Dermatology (2013), Volume 133 & 2013 The Society for Investigative Dermatology
The present study was performed to clarify the less well-
known roles of PTTG1 in the pathophysiology of psoriasis and
functions of TNF-a in keratinocyte proliferation and differen-
tiation using cultured keratinocytes.
RESULTS
PTTG1 expression is enhanced in the psoriatic epidermis
As demonstrated in our recent study (Ishitsuka et al., 2012),
PTTG1 may have a critical role in keratinocyte proliferation.
First, to confirm the impact of aberrantly expressed PTTG1 on
keratinocyte proliferation, PTTG1 was constitutively
overexpressed in normal human keratinocytes (NHKs) and
WST1 proliferation assay was performed. NHK-overexpressing
PTTG1 showed higher proliferation capacity than controls
(Figure 1a). Next, to confirm the expression profile of PTTG1
in psoriatic epidermis, immunofluorescence and immunohis-
tochemical staining for PTTG1 were performed in specimens
obtained from patients with psoriasis (n¼ 12) and normal
controls (n¼6), and its expression levels were compared
among normal (Figure 1b), marginal (n¼ 10) (Figure 1c), and
lesional (n¼12) (Figure 1d) areas along with the cell cycle
marker Ki67 (Gerdes et al., 1984), the initial differentiation
marker keratin 10 (K10) (Roop et al., 1983; Regnier et al.,
1986), and the terminal differentiation marker filaggrin (FLG)
(Fisher et al., 1987; Rothnagel et al., 1987). In the normal
controls and the marginal areas of the psoriatic epidermis,
PTTG1 was expressed in the basal and peribasal keratinocytes,
and was localized in the nucleus and cytoplasm (Figure 1b
and c). Reflecting the cell cycle–dependent expression of
PTTG1 (Ramos-Morales et al., 2000), PTTG1 and Ki67 tended
to be colocalized. There were no apparent aberrations in
differentiation status as indicated by the expression patterns of
K10 and FLG, in comparison with the normal controls
(Figure 1b and c). On the other hand, PTTG1 expression
was enhanced in the lesional areas of psoriatic epidermis;
there were increased numbers of PTTG1-positive keratino-
cytes, and even keratinocytes above the peribasal layers
showed strong immunoreactivity (Figure 1d). Similarly, the
number of Ki67-positive keratinocytes was increased
(Figure 1d). Irrespective of the lesional or marginal areas, the
numbers of PTTG1- and Ki67-positive keratinocytes were
significantly increased in the psoriatic epidermis compared
with the normal controls (Figure 1e). On the other hand, the
expression levels of K10 and FLG were significantly decreased
in the lesional areas compared with the marginal areas and the
normal controls (Figure 1d and e). Taken together, these
findings suggested that the enhanced expression of PTTG1 is
associated with the disease activity characterized by enhanced
proliferation and impaired differentiation of the epidermis.
PTTG1 expression is induced by the EGFR-mediated proliferation
signal in keratinocytes
Proliferation of epidermal keratinocytes is regulated by a
variety of mediators represented by ligands of EGFR, including
EGF and transforming growth factor-a (TGF-a; Cohen, 1962;
Carpenter et al., 1975; Massague, 1983). Overproduction of
such ligands is one of the characteristic features of chronic
inflammatory disorders, including psoriasis (Mascia et al.,
2003). To analyze their effects on keratinocyte proliferation
and PTTG1 expression, neonatal mouse keratinocytes (NMKs)
(Figure 2a and b) and NHKs (Figure 2c and d) were cultured
and stimulated with different doses of EGF and TGF-a,
respectively. First, the effects of EGFR ligands on keratinocyte
proliferation were analyzed. As expected, the ligands
enhanced keratinocyte proliferation as determined by WST1
proliferation assay (Figure 2a and c). Next, the effects of the
EGFR ligands on transactivation of PTTG1 were analyzed by
quantitative real-time (RT) PCR in the keratinocytes. The
ligands induced PTTG1 messenger RNA (mRNA) expression
in a dose-dependent manner (Figure 2b and d). These results
suggested that PTTG1 is closely associated with proliferation
capacity, and its expression is induced by the EGFR-mediated
proliferation signal.
Overexpression of PTTG1 in keratinocytes induces the
production of TNF-a
TNF-a is known to be overexpressed in the psoriatic epidermis
and to have a key role in the pathophysiology of psoriasis
(Kristensen et al., 1993; Ettehadi et al., 1994). Anti-TNF-a
therapy can restore normal epidermal differentiation in
patients with psoriasis (Kim et al., 2011; Donetti et al.,
2012). On the other hand, the expression of PTTG1 in the
lesional areas was enhanced, and overexpression of PTTG1 in
cultured keratinocytes suppressed differentiation (Ishitsuka
et al., 2012). Therefore, it would be significant to analyze
the effects of PTTG1 on TNF-a production in keratinocytes.
First, the expression of TNF-a in cultured NHKs
overexpressing PTTG1 was analyzed by immunoblotting and
quantitative RT–PCR. The results indicated the upregulation of
TNF-a in NHKs overexpressing PTTG1 (Figure 3a and b).
Next, the concentration of TNF-a in the conditioned medium
obtained from NHK cell cultures was analyzed by ELISA. The
level of TNF-a secretion was increased by PTTG1 overexpres-
sion (Figure 3c). These results suggested that PTTG1 induces
TNF-a production in keratinocytes.
PTTG1 expression is induced by TNF-a
Although TNF-a has been implicated in a range of cellular
processes, including proliferation and differentiation via the
activation of transcription factors (Aggarwal et al., 2012), its
effects on the regulation of PTTG1 expression remain
unknown. Therefore, to clarify the effects of TNF-a on
PTTG1 expression in keratinocytes, NMKs were cultured in
medium containing different doses of TNF-a, and PTTG1
expression was analyzed by immunoblotting and
quantitative RT–PCR. These analyses indicated that PTTG1
expression was induced by TNF-a in a dose-dependent
manner (Figure 4a and b). Taken together with the observation
that PTTG1 enhances the production of TNF-a, these findings
strongly suggested a positive feedback cycle between PTTG1
and TNF-a.
TNF-a suppresses keratinocyte differentiation
Overexpression of PTTG1 suppressed keratinocyte differentia-
tion (Ishitsuka et al., 2012), and its expression was induced by
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TNF-a in NMKs. Therefore, to determine whether TNF-a itself
alters keratinocyte differentiation, cultured NMKs (Figure 5a
and b) and NHKs (Figure 5c) were induced to undergo
differentiation by adding high concentrations of Ca2þ to the
medium containing different doses of TNF-a. Immunoblotting
and quantitative RT–PCR indicated dose-dependent decreases
in expression levels of the early differentiation markers keratin
1 (K1), K10, and the terminal differentiation marker loricrin in
NMKs (Figure 5a and b). On the other hand, the expression
levels of K1, K10, FLG, and loricrin mRNA in NHKs were
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Figure 1. Pituitary tumor transforming gene 1 (PTTG1) expression is enhanced in the psoriatic epidermis. (a) PTTG1 was overexpressed in normal human
keratinocytes (NHKs) via a retroviral vector and cultured in 96-well plates. Proliferation capacity was analyzed by the WST1 proliferation assay. The absorbance
values at 440 nm was significantly increased in PTTG1-overexpressing NHKs compared with NHKs carrying a control vector (CTR). The experiments were
repeated at least three times. (b–d) Sections of the samples obtained from patients with psoriasis and normal skin were incubated with an antibody against PTTG1
along with the proliferation marker Ki67, early differentiation marker keratin 10 (K10), and terminal differentiation marker filaggrin (FLG). Antibody binding was
visualized using fluorescent antibodies with a confocal microscope. PTTG 1 was stained green and other immunogens were stained red. Representative images of
(b) normal control and (c) marginal area of psoriatic epidermis. PTTG1 and Ki67 were located in the basal or peribasal layer. PTTG1 was expressed in the
cytoplasm and the nucleus, and partially colocalized with Ki67 in the nucleus. K10 was expressed in the suprabasal layers and FLG was expressed in the granular
layer. (d) Representative images of lesional area of the psoriatic epidermis. The numbers of keratinocytes positive for PTTG1 and Ki67 were increased. Stained
keratinocytes were seen even in the middle layer of the epidermis. The expression levels of K10 and FLG were markedly decreased compared with the lesional
area or the normal controls. White bars represent 100 mm. (e) Immunohistochemical staining was performed in samples obtained from patients with psoriasis
(lesional area, n¼12; marginal area, n¼ 10; normal skin, n¼6). The expression levels of PTTG1, Ki67, K10, and FLG were evaluated and compared among the
groups. The numbers of PTTG1- and Ki67-positive keratinocytes were significantly increased in the lesional areas compared with the marginal areas and the
normal controls. The positivity rates were higher in the marginal area than in the normal controls. The expression levels of K10 and FLG were significantly
decreased in the lesional area compared with the marginal areas or normal controls, whereas there were no significant differences between the marginal areas and
the normal controls. The bottom of the black boxes and top of the white boxes indicate the lower and upper quartiles, respectively. The borders of the black and
white boxes represent the medians. The whiskers with black dots crossing the boxes represent the means. The lower and upper whiskers indicate the minimum and
maximum values, respectively. *Po0.05 vs. control; **Po0.01 vs. control; DAPI, 406-diamidino-2-phenylindole; HPF, high-power field; NS, not significant.
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decreased in the presence of TNF-a (Figure 5c). These results
suggested that TNF-a suppresses keratinocyte differentiation.
PTTG1 overexpression in the psoriatic epidermis involves
augmented expression of cyclin A and B1 proteins
A number of molecules related to the cell cycle are aberrantly
expressed in the hyperproliferative psoriatic epidermis
(Miracco et al., 2000; Santos-Briz et al., 2009; Abou EL-Ela
et al., 2010). Cyclins are known to regulate their binding
partners, the cyclin-dependent kinases, and they drive the cell
cycle transition at specific phases of the cell cycle (Quereda
and Malumbres, 2009). Therefore, to analyze the effects of
PTTG1 overexpression on cell cycle transition in the psoriatic
epidermis, the expression profiles of cyclin A and B1 proteins
were compared between cultured NHKs overexpressing
PTTG1 and the psoriatic epidermis. In cultured NHKs,
immunoblotting revealed that PTTG1 overexpression caused
significant upregulation of cyclin A and B1 (Figure 6a). On the
other hand, the lesional areas of psoriasis (n¼12) showed
significantly increased expression levels as indicated by the
numbers of cyclin A– or cyclin B1–positive keratinocytes,
compared with marginal areas (n¼10) and normal controls
(n¼ 6), although there were no significant differences between
the marginal areas and the normal controls (Figure 6c). These
findings suggested that overexpression of PTTG1 in the
psoriatic epidermis involves augmented cyclin A and B1
protein expression and may result in aberrant regulation of
the cell cycle.
DISCUSSION
TNF-a is known to have a pivotal role in the pathophysiology
of psoriasis (Nickoloff et al., 1991), and therapeutic methods
targeting this molecule are highly effective (Langley, 2012). In
psoriatic lesions, not only macrophages (Clark and Kupper,
2006) and dendritic cells (Lowes et al., 2005) located in the
dermis but also epidermal keratinocytes are the sources
of TNF-a (Kristensen et al., 1993; Ettehadi et al., 1994).
We demonstrated that the production of TNF-a in keratino-
cytes was induced by PTTG1, the expression of which was
increased by the EGFR-mediated proliferation signal and
enhanced in the psoriatic epidermis associated with disease
activity. The addition of TNF-a to NMK cell cultures increased
the expression levels of PTTG1 and reduced the expression
levels of differentiation markers in cultured NMKs and NHKs.
Finally, PTTG1 overexpression involved the augmented cyclin
A and B1 protein expression in both cultured NHKs and
psoriatic epidermis.
PTTG1 had a positive effect on keratinocyte proliferation
(Ishitsuka et al., 2012), and PTTG1 expression was induced by
the EGFR-mediated proliferation signal as demonstrated in
earlier studies (Vlotides et al., 2006; Vlotides et al., 2008).
Moreover, we confirmed increased secretion of EGF from
cultured NHKs overexpressing PTTG1 by ELISA (data not
shown). Therefore, the regulation of PTTG1 expression in
keratinocytes may involve autoinduction depending on the
proliferation status modulated by the EGFR-mediated signal,
and this positive feedback cycle between PTTG1 and EGFR
1.5 **
*
*
**
**
**
**
**
**1.5
1 1
0.5 0.5
0
0.6
1.5
1
0.5
0
0
TGF-α (ng ml–1)
0.4 2 10
0.4
NS
*
*
0.2
0Ab
so
rb
an
ce
 (4
40
 nm
)
m
R
N
A 
ex
pr
es
sio
n
re
la
tiv
e
 to
 G
AP
DH
0
TGF-α (ng ml–1)
0.4 2 10
0
0 1.6 4 10
m
R
N
A 
ex
pr
es
sio
n
re
la
tiv
e
 to
 G
AP
DH
Ab
so
rb
an
ce
 (4
40
 nm
)
0
EGF (ng ml–1) EGF (ng ml–1)
1.6 4 10
Figure 2. Pituitary tumor transforming gene 1 (PTTG1) expression is induced by the EGFR-mediated proliferation signal in keratinocytes. (a, b) Neonatal
mouse keratinocytes (NMKs) were cultivated in growth medium containing different doses of EGF (0, 1.6, 4, and 10 ng ml 1). (c, d) Normal human keratinocytes
(NHKs) were cultivated in growth medium containing different doses of transforming growth factor-a (TGF-a; 0, 0.4, 2, and 10 ng ml1). The (a) NMKs
and (c) NHKs were cultured in 96-well plates, and proliferation capacities of the keratinocytes were analyzed by the WST1 proliferation assay. Absorbance
values at 440 nm were increased by EGF or TGF-a in a dose-dependent manner. Total messenger RNA (mRNA) was extracted from the (b) NMK and (d) NHK
cultures, and the expression of PTTG1 was analyzed by quantitative real-time PCR. The expression levels of PTTG1 were increased in EGF and TGF-a
dose-dependent manner. All data are means±SEM from at least three independent experiments. *Po0.05 vs. control; **Po0.01 vs. control. NS, not significant.
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ligands appears to synergistically promote keratinocyte
proliferation.
On the other hand, PTTG1 induced the production of
TNF-a, and TNF-a itself had an inductive effect on PTTG1
expression in cultured NMKs. As PTTG1 had a positive effect
on keratinocyte proliferation (Ishitsuka et al., 2012), PTTG1
and TNF-a appear to have a synergistic effect on proliferation,
and regulation of their expression may involve autoinduction,
as seen in the EGFR ligands. However, there are some
discrepancies regarding the effects of TNF-a on keratinocyte
proliferation in vitro; several studies indicated a suppressive
effect (Pillai et al., 1989; Kono et al., 1990; Banno et al.,
2004), whereas others showed an enhancing effect (Ziv et al.,
2008; Takahashi et al., 2009). Indeed, although we attempted
to confirm the positive effect of TNF-a on keratinocyte
proliferation and the expression levels of PTTG1 in cultured
NHKs, our results were inconclusive (data not shown).
Although these discrepancies may have been due to
differences in experimental settings, earlier studies using
TNF-a (–/–) mice support our findings; the mice showed
decreased proliferation capacity of keratinocytes in the
early stages of chemical carcinogenesis, characterized by
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was analyzed by quantitative real-time PCR. NHKs overexpressing PTTG1
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concentration of TNF-a in conditioned medium obtained from the NHK
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Figure 4. Pituitary tumor transforming gene 1 (PTTG1) expression is induced
by transforming growth factor-a (TNF-a). Neonatal mouse keratinocytes
(NMKs) were cultured with different doses of TNF-a (0, 2, 10 ng ml1)
in growth medium, and the expression levels of PTTG1 were analyzed.
(a) Whole-cell lysates obtained from NHK cultures were subjected to
immunoblotting analysis. PTTG1 expression levels were increased in
a TNF-a dose-dependent manner. The graph indicates the expression of PTTG1
relative to b-actin (loading control) as determined by densitometry. (b) Total
messenger RNA (mRNA) was extracted from NMK cultures, and the expression
of PTTG1 was analyzed by quantitative real-time PCR. The levels of
PTTG1 expression relative to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were increased in a TNF-a dose-dependent manner. All data are
means±SEM from at least three independent experiments. *Po0.05 vs.
control; **Po0.01 vs. control.
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keratinocyte hyperproliferation and inflammation (Moore
et al., 1999; Suganuma et al., 1999). In addition to
keratinocyte proliferation, we also demonstrated a
suppressive effect of TNF-a on early differentiation of
keratinocytes, in addition to terminal differentiation, as
reported previously (Kim et al., 2011). As proliferation and
differentiation are generally independent processes, the
suppression of early differentiation may have been due to
enhanced proliferation mediated by TNF-a; that is, TNF-a may
enhance proliferation and suppress differentiation of
keratinocytes, and PTTG1 may be involved in this regulatory
mechanism by modulating the production of TNF-a.
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Figure 5. Transforming growth factor-a (TNF-a) suppresses keratinocyte differentiation. (a) Cultured neonatal mouse keratinocytes (NMKs) were differentiated
by adding 0.35 mM Ca2þ to the medium containing different doses of TNF-a (0, 2, 10 ng ml1). Whole-cell lysates obtained from NMK cultures were
subjected to immunoblotting analysis. The expression levels of K1, K10, and loricrin were decreased in a TNF-a dose-dependent manner. The graphs indicate
their expression relative to b-actin (loading control) as determined by densitometry. (b) Total messenger RNA (mRNA) was extracted from NMK cultures,
and the expression levels of the differentiation markers were analyzed by quantitative real-time PCR. The expression levels of K1, K10, and loricrin relative to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were decreased in a TNF-a dose-dependent manner. (c) Cultured NHKs were differentiated by adding
1.5 mM Ca2þ to the medium containing different doses of TNF-a (0, 2, 10, 50, 250 mg ml 1). Total mRNA was extracted from NHK cultures, and the expression
levels of the differentiation markers were analyzed by quantitative real-time PCR. The expression levels of K1, K10, filaggrin, and loricrin relative to GAPDH
were decreased in the presence of TNF-a. In particular, the expression levels of K10 and loricrin relative to GAPDH were decreased in a TNF-a dose-dependent
manner. All data are means±SEM from three independent experiments. *Po0.05 vs. control; **Po0.01 vs. control. NS, not significant.
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We also demonstrated that PTTG1 in the psoriatic epidermis
involves augmented expression of cyclin A and B1 proteins,
the regulators of the cell cycle abundantly expressed in the
S/G2 and G2/M phases of the cell cycle, respectively (Quereda
and Malumbres, 2009). As PTTG1 protein is known to be
abundant in these phases of the cell cycle (Ramos-Morales
et al., 2000), there may be some interactions between PTTG1
and the cyclin proteins, as suggested in earlier studies (Cohen-
Fix and Koshland, 1999; Marangos and Carroll, 2008; Tinker-
Kulberg and Morgan, 1999). Moreover, a previous study
suggested that psoriasis is characterized by enhanced cyclin A
and B protein expression in the epidermis (Miracco et al.,
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Figure 6. Pituitary tumor transforming gene 1 (PTTG1) overexpression in the psoriatic epidermis involves augmented expression of cyclin A and B1 proteins.
The expression levels of cyclin A and B1 proteins were analyzed in cultured normal human keratinocytes (NHKs) and the samples obtained from patients
with psoriasis and normal skin. (a) PTTG1 was overexpressed in NHKs, and the expression levels of PTTG1, cyclin A, and cyclin B1 were analyzed by
immunoblotting. NHKs overexpressing PTTG1 showed the upregulation of cyclin A and B1 compared with the control (CTR). The graphs indicate their expression
relative to b-actin (loading control) as determined by densitometry. (b) Sections of the samples obtained from patients with psoriasis (lesional area, n¼ 12;
marginal area, n¼ 10) and normal controls (n¼6) were subjected to immunohistochemical staining with antibodies against cyclin A and B1. Representative
images are shown. Keratinocytes positive for cyclin A are indicated by arrowheads. In normal skin and marginal areas of psoriasis, cyclin A and B expression
were mainly confirmed in the basal or peribasal keratinocytes, located in the cytoplasm and nucleus. The numbers of keratinocytes positive for cyclin A and B1
were increased in the lesional areas of psoriatic epidermis compared with normal skin or marginal areas. Black bars represent 100 mm. (c) The numbers of
keratinocytes positive for PTTG1, cyclin A, and cyclin B1 per high-power field (HPF) were analyzed statistically in the samples. The numbers of keratinocytes
positive for cyclin A and B1 in the lesional areas were significantly larger than those in the marginal areas or normal controls. However, there were no
significant differences between the marginal areas and normal controls. The bottom of the black boxes and top of the white boxes indicate the lower and upper
quartiles, respectively. The borders of the black and white boxes represent the medians. The whiskers with black dots crossing the boxes represent the means.
The lower and upper whiskers represent the minimum and maximum values, respectively. *Po0.05 vs. control; **Po0.01 vs. control. NS, not significant.
Y Ishitsuka et al.
PTTG1 Induces TNF-a Production
2572 Journal of Investigative Dermatology (2013), Volume 133
2000). Taken together, PTTG1 overexpression in the epidermis
seems to be closely related to abundant cyclin proteins and
may be one of the characteristic features of psoriasis.
In conclusion, we demonstrated enhanced expression of
PTTG1 in the psoriatic epidermis and its role in the patho-
physiology of psoriasis characterized by aberrantly regulated
keratinocyte proliferation/differentiation. Moreover, as a
recent genetic study indicated that PTTG1 is a psoriasis
susceptibility gene (Sun et al., 2010; Chandran, 2012; Yang
et al., 2012), dysregulated expression of PTTG1 may
contribute to disease progression. These observations
suggested that PTTG1 is a key molecule and a potential
therapeutic target of psoriasis.
MATERIALS AND METHODS
Immunofluorescence staining
Representative samples obtained from patients with psoriasis cut into
sections at a thickness of 3mm were deparaffinized and subjected to
antigen retrieval and blocking with phosphate-buffered saline (PBS,
pH 7.2) containing 10% goat serum, followed by overnight incuba-
tion with 1:1 mixtures of diluted primary antibodies (PTTG1,
10mg ml 1, ab-79546; ABcam, Cambridge, MA; Ki67, 1/25000, ab-
86373; ABcam; K10, 10 , MON 3025; Sanbio B.V., Uden, The
Netherlands; FLG, 2.5mg ml 1, MS-449; Thermo Fisher Scientific,
Newark, DE). Antibody binding was visualized by incubation with a
1:1 mixture of secondary antibodies (anti-rabbit IgG-FITC, 2 mg ml 1,
sc-2012, and anti-mouse IgG-TR, sc-2781, 20 mg ml 1; Santa Cruz
Biotechnology, Santa Cruz, CA) for 60 minutes at room temperature,
followed by mounting with medium containing 406-diamidino-2-
phenylindole (DAPI; VECTASHIELD mounting medium with DAPI,
H-1200; Vector Laboratories, Burlingame, CA). A confocal micro-
scopy system (TCS SP5; Leica Microsystems, Wetzlar, Germany) was
used to observe and record the fluorescence.
Immunohistochemical staining
The deparaffinized sections were incubated overnight with primary
antibodies diluted as follows after routine antigen retrieval and
blocking: PTTG1, 10mg ml 1, ab-79546; ABcam; K10, 100,
MON3025; Sanbio B.V.; Ki67, 0.05mg ml 1, ab15580; ABcam;
FLG, 2.5 mg ml 1, MS-449; Thermo Fisher Scientific; cyclin A,
2 mg ml 1 RB-1548; Thermo Fisher Scientific; cyclin B1,
0.5 mg ml 1 05-373; Millipore, Billerica, MA. After blocking of
endogenous peroxidase with PBS containing 0.3% NaN3 and
0.01% H2O2, visualization was performed using an EnVision system
according to the standard protocol (Dako, Glostrup, Denmark),
followed by light counterstaining with hematoxylin. PTTG1-, Ki67-,
cyclin A–, and B1–positive keratinocytes were counted in high-power
fields by two independent dermatologists (YI and YK) using a digital
microscope (AX80; Olympus, Tokyo, Japan) and Flovel Filing System
(Flovel, Tokyo, Japan), and the positivity rates for each immunogen
were subjected to statistical analyses. According to the known
intracellular locations, keratinocytes showing positivity in the cyto-
plasm and nucleus were counted as PTTG1-, cyclin A–, and cyclin
B1–positive (Pines and Hunter, 1991Hagting et al., 1999; Marangos
and Carroll, 2008; Panguluri et al., 2008), whereas nuclear staining
was counted as Ki67 positivity (Gerdes et al., 1984). Expression of
K10 (1–4) was evaluated according to the numbers of K10-negative
layers: Grade 1, all layers; Grade 2, 5–10 layers; Grade 3, 2–4 layers;
Grade 4, one layer. Expression of FLG was evaluated according to the
staining intensity scored on a scale from 0 to 4, with 0 indicating no
staining and 4 indicating the most intense staining. Samples of
marginal skin obtained from patients with nevocellular nevus
(n¼ 6) were used as normal controls.
Cell culture
Normal human neonatal or adult keratinocytes (NHKs) (KJB-100; DS
Pharma, Osaka, Japan; FC-0007; Lifeline Cell Technology, Ocean-
side, CA) were cultured in serum-free growth medium (KJB-200; DS
Pharma; LL-0007; Lifeline Cell Technology; 195130; Lonza, Basel,
Switzerland), in accordance with the manufacturer’s instructions.
Constitutive overexpression of PTTG1 was obtained by transduction
via retroviral vector as described previously (Fujisawa et al., 2009;
Ishitsuka et al., 2012). NHKs and primary mouse keratinocytes
prepared as described previously (Rothnagel et al., 1993) were
maintained at 80% confluency for 48 hours in growth medium
containing 0.05 mM (NMK) or 0.06 mM (NHK) CaCl2 with the
indicated concentrations of human recombinant EGF (050-07141;
Wako, Osaka, Japan), TGF-a (201-18341; Wako), and TNF-a (210-
TA-010; R&D Systems, Minneapolis, MN) at 37 1C in 5% CO2. NMKs
were differentiated by maintaining it in medium containing 0.35 mM
CaCl2 and TNF-a at the indicated concentration for 48 hours
following cultivation in EGF-free medium for 48 hours. Similarly,
after depletion of EGF from the growth medium for 24 hours, NHKs
were differentiated by maintaining them in medium containing
1.5 mM CaCl2 and TNF-a at the indicated concentration for
96 hours with replacement of the medium at 48 hours. NHKs at
third passage were used for the experiments.
Immunoblotting
Cells at 80–90% confluency in culture dishes were solubilized using
sample buffer solution (Wako). The whole-cell lysates were subjected
to SDS-PAGE on Mini-PROTEAN TGX Precast Gels (Bio-Rad, Her-
cules, CA), and the proteins were transferred onto nitrocellulose
membranes (GE Healthcare, Buckinghamshire, UK). The membranes
were incubated overnight with primary antibodies against PTTG1
(10mg ml 1, ab-79546; ABcam), K10 (0.2mg ml 1, PRB-159P; Cov-
ance, Emeryville, CA), K1 (0.2 mg ml 1, PRB-165P; Covance), keratin
5 (0.2mg ml 1, PRB-160P; Covance), loricrin (0.5mg ml 1, PRB-
165P; Covance), TNF-a (13mg ml 1, GTX10205; GenTex, San
Antonio, TX), cyclin A (10mg ml 1 RB-1548; Thermo Fisher Scien-
tific), cyclin B1 (0.5mg ml 1 05-373; Millipore), and b-actin
(0.2mg ml 1; BioVision, Mountain View, CA), followed by incuba-
tion for 60 minutes with HRP-labeled secondary antibodies against
rabbit IgG (0.04mg ml 1; Santa Cruz) or mouse IgG (0.4mg ml 1;
Santa Cruz). Antibody binding was visualized and enhanced with
SuperSignal West Dura Chemiluminescent Substrate (Thermo Fisher
Scientific) and an image analysis system (LAS4000 mini; Fujifilm,
Tokyo, Japan). The intensities of the bands were quantified using the
Image J software (NIH, Bethesda, MD), and the expression levels were
normalized relative to b-actin.
Quantitative RT–PCR analysis
Total RNA was extracted from culture dishes at 80–90% confluency
using ISOGEN II (Nippon Gene, Tokyo, Japan), and cDNA was
synthesized using a reagent kit (Prime Script RT reagent kit; Takara
Bio, Shiga, Japan). A sequence detection system (ABI PRISM 7500;
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Applied Biosystems, Foster City, CA) was used for SYBR Green (Takara
Bio)–based quantitative analysis. The quantity of mRNA was normal-
ized relative to that of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). The extracted RNA with OD260/OD280 ratio41.8 was
subjected to analysis, and quantification was performed in triplicate.
The primers used were as follows: TNF-a (human) (forward: 50-TA
TGGCCCAGACCCTCACA-30; reverse: 50- GGAGTAGACAAGGT
ACAACCCATC-30); PTTG1 (human) (forward: 50- CCCTTGAGTG
GAGTGCCTCT-30; reverse: 50- CACAGCAAACAGGTGGCAAT-30);
K1 (human) (forward: 5’-AGATCACTGCTGGCAGACATGG-30; reverse:
50-TGATGGACTGCTGCAAGTTGG-30); K10 (human) (forward:
50- CAACATCCTGCTTCAGATCGAC-30; reverse: 50- GCGCAGAGCT
ACCTCATTCTCA-30); FLG (human) (forward: 50- CATGGCAGCT
ATGGTAGTGCAGA-30; reverse 50-ACCAAACGCACTTGCTTTACA
GA-30); Loricrin (human) (forward: 50- GGCTGCATCTAGTTC
TGCTGTTTA-30; reverse 50- CAAATTTATTGACTGAGGCACTGG-
30); GAPDH (human) (forward: 50- GCACCGTCAAGGCTGAGA
AC-30; reverse 50- TGGTGAAGACGCCAGTGGA-30); PTTG1 (mouse)
(forward: 50-TTTGGCATCTAAGGATGGGTTGA-30; reverse: 50-AGC
ATTGAACACTTTGCCGACTC-30); K1 (mouse) (forward: 50-AGAAC
ATGCAAGACCTGGTGGA-30; reverse: 50-TCTTGATGGTCACGA
ACTCATTCTC-30); K10 (mouse) (forward: 50-CTGACAATGCCAA
CGTGCTG-30; reverse: 50-GCAGGGTCACCTCATTCTCGTA-30);
Loricrin (mouse) (forward: 50-GGTTGCAACGGAGACAACAGA-30;
reverse 50-TTGGAAACCTCAGGCAAATTCA-30); GAPDH (mouse)
(forward: 50-AAATGGTGAAGGTCGGTGTGAAC-30; reverse 50-CAA
CAATCTCCACTTTGCACTG-30).
ELISA
The conditioned media were obtained from NHKs overexpressing
PTTG1 cultured under monolayer conditions. The concentrations of
TNF-a were analyzed using an assay kit (EA-1041; Signosis, Sunny-
vale, CA) in accordance with the manufacturer’s protocol. The
absorbance values were analyzed by fluorometry (Varioskan; Thermo
Fisher Scientific) and given in arbitrary units relative to the values of
the control for TNF-a.
Cell proliferation assay
Keratinocytes were grown in triplicate cultures in 96-well plates at a
density of 5 104 per well (NMKs) or 1 104 per well (NHKs) in
medium containing the indicated concentrations of EGFR ligands for
72 hours. NHKs overexpressing PTTG1 and the control cells were
cultured in medium containing 2 ng ml 1 TGF-a. WST1 premix (MK
400; Takara Bio) was added to the culture in accordance with the
manufacturer’s protocol. The absorbance values at 440 nm were
analyzed by fluorometry (Varioskan; Thermo Fisher Scientific).
Statistical analysis
Data are expressed as means±SEM. Comparisons among groups
were performed with the paired Student’s t-test. In all analyses,
Po0.05 was taken to indicate statistical significance.
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